Company intelligence
IRBM
#IRBM — powerful integrated drug discovery from concept to candidate.
About IRBM
IRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, unified research facility to accelerate team-based breakthroughs and improve efficiencies from concept to candidate. With a history of contributing to several approved drugs, and its own internal pipeline of oncology and other therapeutic assets, IRBM is powered by deep collaborations and decades of expertise from leading global institutions. Their comprehensive in-house capabilities assist partners in achieving key milestones and progressing towards clinical readiness, positioning IRBM as a major player in driving innovation in the pharmaceutical and biotech fields. Find more detailed information available on our website below.
Verified activity
Signals from IRBM
6 published signals
Presence & Recognition
IRBM employee Claudia Dall'Armi participated in the EPS Meeting in Vienna with colleagues Danila B., Stefania Colarusso, and Ali Hoseini, PhD, MBA.
Reported by Claudia Dall'Armi
Presence & Recognition
IRBM is attending the EFMC meeting at booth 56.
Reported by Els Saesen
Presence & Recognition
IRBM hosted Christian A. G. N. Montalbetti, Director of Medicinal Chemistry, and Emanuela N. peptide and macrocycle drug discovery expert at the European Federation for Medicinal Chemistry and Chemical Biology.
Reported by Els Saesen
Presence & Recognition
IRBM employees Emanuela N. and Christian A. G. N. Montalbetti are attending the EFMC 2026 European Federation for Medicinal Chemistry and Chemical Biology at booth 56
Reported by Els Saesen
Presence & Recognition
IRBM is attending EPS 2026 in Vienna to explore what's possible when great peptide programs meet the right capabilities.
Reported by Ali Hoseini, PhD, MBA
People
IRBM is hiring for a team member based out of Boston on September 22nd
Reported by Els Saesen